Association Between Fatigue, Peripheral Serotonin, and L-carnitine in Hypothyroidism and in Chronic Fatigue Syndrome

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Mar 20

PMID 38505756

Authors

Tommi Raij

Kari Raij

Affiliations

Soon will be listed here.

Abstract

Background: Fatigue of unknown origin is a hallmark symptom in chronic fatigue syndrome (CFS) and is also found in 20% of hypothyroidism patients despite appropriate levothyroxine treatment. Here, we suggest that in these disorders, peripheral serotonin levels are low, and elevating them to normal range with L-carnitine is accompanied with reduced fatigue.

Methods: We conducted a retrospective analysis of follow-up clinical data (CFS N=12; hypothyroidism with fatigue N=40) where serum serotonin and fatigue levels were compared before after 7 weeks of oral L-carnitine supplementation.

Results: After L-carnitine, serotonin increased (8-fold in CFS, Sig. = 0.002, 6-fold in hypothyroidism, Sig. < 0.001) whereas fatigue decreased (2-fold in both CFS and hypothyroidism, Sig. = 0.002 for CFS, Sig. < 0.001 for hypothyroidism). There was a negative correlation between serotonin level and fatigue (for CFS, rho = -0.49 before and -0.67 after L-carnitine; for hypothyroidism, rho = -0.24 before and -0.83 after L-carnitine).

Conclusions: These findings suggest a new link between low peripheral serotonin, L-carnitine, and fatigue.

Citing Articles

Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Aetiology and Potential Treatments.

Bansal A, Seton K, Brooks J, Carding S Int J Mol Sci. 2025; 26(5).

PMID: 40076522 PMC: 11899462. DOI: 10.3390/ijms26051896.

Exertional Exhaustion (Post-Exertional Malaise, PEM) Evaluated by the Effects of Exercise on Cerebrospinal Fluid Metabolomics-Lipidomics and Serine Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Baraniuk J Int J Mol Sci. 2025; 26(3).

PMID: 39941050 PMC: 11818353. DOI: 10.3390/ijms26031282.

Is the acquired hypothyroidism a risk factor for developing psychiatric disorders?.

Osnaya-Brizuela N, Valenzuela-Peraza A, Santamaria-Del Angel D, Garcia-Martinez Y, Pacheco-Rosado J, Perez-Sanchez G Front Psychiatry. 2024; 15:1429255.

PMID: 39100850 PMC: 11294236. DOI: 10.3389/fpsyt.2024.1429255.

References

Wolfe F, Russell I, Vipraio G, Ross K, Anderson J . Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 1997; 24(3):555-9. View

Nagy-Szakal D, Barupal D, Lee B, Che X, Williams B, Kahn E . Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. 2018; 8(1):10056. PMC: 6030047. DOI: 10.1038/s41598-018-28477-9. View

Peterson S, McAninch E, Bianco A . Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?. J Clin Endocrinol Metab. 2016; 101(12):4964-4973. PMC: 6287526. DOI: 10.1210/jc.2016-2660. View

Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S . A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J Transl Med. 2020; 18(1):290. PMC: 7392668. DOI: 10.1186/s12967-020-02452-3. View

Louwerens M, Appelhof B, Verloop H, Medici M, Peeters R, Visser T . Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism. Eur J Endocrinol. 2012; 167(6):809-15. DOI: 10.1530/EJE-12-0501. View

Billones R, Liwang J, Butler K, Graves L, Saligan L . Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions. Brain Behav Immun Health. 2021; 15:100266. PMC: 8474156. DOI: 10.1016/j.bbih.2021.100266. View

Spinelli R, Baboota R, Gogg S, Beguinot F, Bluher M, Nerstedt A . Increased cell senescence in human metabolic disorders. J Clin Invest. 2023; 133(12). PMC: 10266774. DOI: 10.1172/JCI169922. View

Kirkland J, Tchkonia T . Cellular Senescence: A Translational Perspective. EBioMedicine. 2017; 21:21-28. PMC: 5514381. DOI: 10.1016/j.ebiom.2017.04.013. View

Plioplys A, Plioplys S . Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology. 1995; 32(3):132-8. DOI: 10.1159/000119226. View

10.

Rutherford G, Manning P, Newton J . Understanding Muscle Dysfunction in Chronic Fatigue Syndrome. J Aging Res. 2016; 2016:2497348. PMC: 4779819. DOI: 10.1155/2016/2497348. View

11.

Wang Q, Zhang H, Xu H, Guo D, Shi H, Li Y . 5-HTR3 and 5-HTR4 located on the mitochondrial membrane and functionally regulated mitochondrial functions. Sci Rep. 2016; 6:37336. PMC: 5118798. DOI: 10.1038/srep37336. View

12.

Schrack J, Simonsick E, Glynn N . Fatigability: A Prognostic Indicator of Phenotypic Aging. J Gerontol A Biol Sci Med Sci. 2020; 75(9):e63-e66. PMC: 7749190. DOI: 10.1093/gerona/glaa185. View

13.

Virmani M, Cirulli M . The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int J Mol Sci. 2022; 23(5). PMC: 8910660. DOI: 10.3390/ijms23052717. View

14.

Jones M, Goodwin C, Amjad S, Chalmers R . Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta. 2005; 360(1-2):173-7. DOI: 10.1016/j.cccn.2005.04.029. View

15.

Myhill S, Booth N, McLaren-Howard J . Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009; 2(1):1-16. PMC: 2680051. View

16.

Namkung J, Kim H, Park S . Peripheral Serotonin: a New Player in Systemic Energy Homeostasis. Mol Cells. 2015; 38(12):1023-8. PMC: 4696992. DOI: 10.14348/molcells.2015.0258. View

17.

Naviaux R, Naviaux J, Li K, Bright A, Alaynick W, Wang L . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2016; 113(37):E5472-80. PMC: 5027464. DOI: 10.1073/pnas.1607571113. View

18.

Minnock P, Kirwan J, Bresnihan B . Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology (Oxford). 2009; 48(12):1533-6. DOI: 10.1093/rheumatology/kep287. View

19.

Miller M, Bostwick B, Kennedy A, Donti T, Sun Q, Sutton V . Chronic Oral L-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions. JIMD Rep. 2016; 30:39-44. PMC: 5110437. DOI: 10.1007/8904_2016_539. View

20.

Hewlett S, Kirwan J, Bode C, Cramp F, Carmona L, Dures E . The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries. Rheumatology (Oxford). 2017; 57(2):300-308. PMC: 5850460. DOI: 10.1093/rheumatology/kex370. View